Infantile Spasms: Clinical Trials

20 trials for Infantile Spasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 withdrawn, 1 recruiting, 1 terminated. 7 Phase 3, 5 Phase 2, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 37Completed 5, Withdrawn 2
Phase 25Completed 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 42Completed 1, Withdrawn 1
Not applicable1Completed 1

Follow Infantile Spasms: new trials by email Literature Review of Infantile Spasms trials Research Report on Infantile Spasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Prevent Infantile Spasms Relapse
Prednisolone, Famotidine, Placebo - Infantile Spasms, Infantile Epileptic Spasms Syndrome
Phase 2RecruitingUniversity of California, Los Angeles402025-05-052025-05-08
Artificial Intelligence-based Video Analysis to Detect Infantile Spasms
Spasm Vision - Infantile Spasms
CompletedJohns Hopkins University612024-08-262026-05-07
Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms
Prednisolone, Vigabatrin - Infantile Spasms
Phase 3WithdrawnThe Hospital for Sick Children2017-09-052019-11-14
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
GWP42003-P - Infantile Spasms
Phase 3CompletedJazz Pharmaceuticals92017-05-122022-09-02
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
GWP42003-P - Infantile Spasms
Phase 3CompletedJazz Pharmaceuticals92017-04-242022-09-02
Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy
Vigabatrin: Vigabatrin new ST formulation then SabrilĀ® - Infantile Spasms
Not applicableCompletedOrphelia Pharma382014-05-012018-04-24
Evaluation of Neuroinflammation in Children With Infantile Spasms
ACTH - Infantile Spasms
Phase 4CompletedWayne State University82013-03-012017-11-07
Genetic Studies in Patients and Families With Infantile Spasms
Infantile Spasms
CompletedUniversity of Colorado, Denver632013-03-012021-06-14
Addition of Pyridoxine to Prednisolone in Infantile Spasms
Pyridoxine plus prednisolone, Prednisolone - Infantile Spasms
Phase 3CompletedLady Hardinge Medical College622012-11-012019-01-15
An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms
Vigabatrin - Infantile Spasms
Phase 4WithdrawnLundbeck LLC2012-06-012012-09-13
Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy
modified Atkins diet, no dietetic input - Infantile Spasms
Phase 2 / Phase 3WithdrawnLady Hardinge Medical College2012-02-012013-04-09
Prednisolone in Infantile Spasms- High Dose Versus Usual Dose
Oral prednisolone - Infantile Spasms, West Syndrome
Phase 3CompletedLady Hardinge Medical College632012-02-012013-04-09
Molecular Genetics in Infantile Spasms
Infantile Spasms, West Syndrome
CompletedHospices Civils de Lyon412010-10-012016-08-31
Use of the Modified Atkins Diet in Infantile Spasms
modified Atkins diet - Infantile Spasms
Phase 2 / Phase 3CompletedAll India Institute of Medical Sciences152009-10-012010-11-22
Sabril Patient Registry
SabrilĀ® - Infantile Spasms, Refractory Complex Partial Seizures in Adults
CompletedLundbeck LLC94232009-08-012016-07-29
Epilepsy Phenome/Genome Project
Epilepsy, Localization-related Epilepsy
CompletedUniversity of California, San Francisco41502007-11-012018-11-13
Open-label Extension to Protocol 1042-0500
Ganaxolone - Infantile Spasms
Phase 2TerminatedMarinus Pharmaceuticals542007-01-012024-05-28
A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms
Ganaxolone, Placebo - Infantile Spasms
Phase 2CompletedMarinus Pharmaceuticals572007-01-012023-06-02
Metabolic Abnormalities in Children With Epilepsy
18 FDG - Generalized Epilepsy, Infantile Spasms
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)801992-04-012008-03-04
Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study
Infantile Spasms
CompletedYonsei University2009-08-28

Narrower conditions

Spasms, Infantile (20)  ·  Seizures (3)  ·  Epilepsies, Partial (2)  ·  Epilepsy (2)  ·  Lennox Gastaut Syndrome (2)  ·  Epilepsy, Complex Partial (1)  ·  Epilepsy, Generalized (1)  ·  Epilepsy, Idiopathic Generalized (1)  ·  Malformations of Cortical Development (1)  ·  Metabolic Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Periventricular Nodular Heterotopia (1)  ·  Polymicrogyria (1)  ·  Recurrence (1)

Broader conditions

Brain Diseases (20)  ·  Central Nervous System Diseases (20)  ·  Epileptic Syndromes (20)  ·  Nervous System Diseases (20)  ·  Epilepsy, Generalized (19)  ·  Epilepsy (18)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Neurologic Manifestations (3)  ·  Signs and Symptoms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Pathologic Processes (2)  ·  Congenital Abnormalities (1)  ·  Disease Attributes (1)  ·  Epilepsies, Partial (1)

Interventions

Prednisolone (4)  ·  Vigabatrin (3)  ·  Cannabidiol (2)  ·  ganaxolone (2)  ·  Adrenocorticotropic Hormone (1)  ·  Famotidine (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Pyridoxine (1)

Sponsors

Lady Hardinge Medical College (3)  ·  Jazz Pharmaceuticals (2)  ·  Lundbeck LLC (2)  ·  Marinus Pharmaceuticals (2)  ·  All India Institute of Medical Sciences (1)  ·  Hospices Civils de Lyon (1)  ·  Johns Hopkins University (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Orphelia Pharma (1)  ·  The Hospital for Sick Children (1)  ·  University of California, Los Angeles (1)  ·  University of California, San Francisco (1)  ·  University of Colorado, Denver (1)  ·  Wayne State University (1)  ·  Yonsei University (1)

Countries

United States (10)  ·  India (4)  ·  Poland (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  France (1)

Top investigators

Satinder Aneja, MD (2)  ·  Carter Snead, MD (1)  ·  Daniel Lowenstein, MD (1)  ·  Eric Kossoff, MD (1)  ·  Rama Chellappa, PhD (1)  ·  Ruben Kuzniecky, MD (1)  ·  Shaun A. Hussain, MD, MS (1)  ·  Sheffali Gulati, MD (1)  ·  Suvasini Sharma, MD, DM (1)  ·  Tim Benke, MD (1)

Results publications

PMID 21920781, PMID 25048310, PMID 29547159, PMID 32917807

NIH funding

2015 (2)